Stock Groups

U.S. CDC chief hopes to make call on COVID boosters for 12-15 year-olds in days, weeks -CNN -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO : This photo shows a teenager receiving a COVID-19 (coronavirus) vaccine from the Philadelphia Department of Public Health. The clinic is a partnership between the Black Doctors COVID-19 Consortium and the Philadelphia Department of Public Health. It was taken to encourage everyone eligible to get vaccinated.

WASHINGTON (Reuters] – The approval of a third vaccine for COVID-19 for children between 12 and 15 years old in the United States could come as soon as next week, according to the head of the Centers for Disease Control and Prevention (CDC), during a CNN interview.

When children could receive a booster shot for their age, Rochelle Walensky, Director of the CDC said that “So, the FDA (Food and Drug Administration), is currently looking into that.” As soon as the CDC hears from them, I hope to get that information in the next few days.

While it wasn’t immediately apparent, Pfizer Inc (NYSE:), and BioNTech Se (NASDAQ:), its partner — the sole manufacturer of COVID-19 vaccinations that is FDA approved for children — filed formal FDA applications for approval for booster doses for children aged 12-15.

Children between 16 and 17 years old in the United States are eligible to receive a third booster shot.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]